Biomarkers in atopic dermatitis and psoriasis-a Delphi-based guide through the jungle?
作者信息
Fehr D, Brüggen M-C
机构信息
Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Faculty of Medicine, University of Zurich, Zurich, Switzerland.
出版信息
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1400-1401. doi: 10.1111/jdv.18422.
Abstract
摘要
相似文献
1
Biomarkers in atopic dermatitis and psoriasis-a Delphi-based guide through the jungle?
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1400-1401. doi: 10.1111/jdv.18422.
2
Mapping ethical and social aspects of biomarker research and its application in atopic dermatitis and psoriasis: a systematic review of reason.
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1201-1213. doi: 10.1111/jdv.18128. Epub 2022 Apr 20.
3
Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1467-1476. doi: 10.1111/jdv.18178. Epub 2022 May 17.
4
The BIOMarkers in Atopic Dermatitis and Psoriasis (BIOMAP) glossary: developing a lingua franca to facilitate data harmonization and cross-cohort analyses.
Br J Dermatol. 2021 Nov;185(5):1066-1069. doi: 10.1111/bjd.20587. Epub 2021 Aug 18.
5
Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis.
Acta Derm Venereol. 2019 Feb 1;99(2):175-180. doi: 10.2340/00015555-3065.
6
Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire.
Acta Derm Venereol. 2011 Sep;91(5):537-40. doi: 10.2340/00015555-1126.
7
[The coexistence of atopic dermatitis and psoriasis in a 12 months-old girl].
Pol Merkur Lekarski. 2005 Oct;19(112):542-4.
8
Limitations of Using Questionnaires for Assessing the Prevalence of Psoriasis and Atopic Dermatitis Among Adults.
JAMA Dermatol. 2021 Aug 1;157(8):971-977. doi: 10.1001/jamadermatol.2021.2307.
9
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in psoriasis and atopic dermatitis: A case-control study.
J Am Acad Dermatol. 2021 Jun;84(6):1707-1708. doi: 10.1016/j.jaad.2020.08.004. Epub 2020 Aug 6.
10
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis.
J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1405-8. doi: 10.1111/j.1468-3083.2009.03327.x.
本文引用的文献
1
Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1467-1476. doi: 10.1111/jdv.18178. Epub 2022 May 17.
2
Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets.
Int J Mol Sci. 2022 Feb 28;23(5):2684. doi: 10.3390/ijms23052684.
3
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.
Nat Rev Drug Discov. 2022 Jan;21(1):21-40. doi: 10.1038/s41573-021-00266-6. Epub 2021 Aug 20.
4
Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients.
Ann Allergy Asthma Immunol. 2021 Sep;127(3):334-341. doi: 10.1016/j.anai.2021.04.023. Epub 2021 May 9.
5
Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council.
J Allergy Clin Immunol. 2021 Apr;147(4):1174-1190.e1. doi: 10.1016/j.jaci.2021.01.013. Epub 2021 Jan 28.
6
Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: Clinical aspects and treatment outcomes in adolescent and adult patients.
Pediatr Dermatol. 2021 Jan;38(1):109-114. doi: 10.1111/pde.14437. Epub 2020 Nov 6.
7
Atopic dermatitis endotypes and implications for targeted therapeutics.
J Allergy Clin Immunol. 2019 Jan;143(1):1-11. doi: 10.1016/j.jaci.2018.10.032.
8
How to use the nominal group and Delphi techniques.
Int J Clin Pharm. 2016 Jun;38(3):655-62. doi: 10.1007/s11096-016-0257-x. Epub 2016 Feb 5.
Zotero 插件